Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02039115 · ClinicalTrials.gov registry record · Phase 4
Reduction in Symptomatic Esophageal Stricture Formation
A Phase 4 study, sponsored by AdventHealth.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02039115: Clinical Trial Phase 4 study, sponsored by AdventHealth.
NCT02039115 is a Phase 4 study that was terminated before completion, run by AdventHealth. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02039115, a Phase 4 study, was terminated before completion, sponsored by AdventHealth.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
Complete endoscopic resection of early neoplastic Barrett's Esophagus (BE) is a curative procedure. However, a significant proportion of patients develop symptomatic esophageal strictures following Complete Barrett's Eradication (CBE), and this limits the technique, particularly for circumferential and longer segment disease. Oral steroid therapy may reduce stricture formation; thereby allowing CBE to be performed with minimal associated morbidity.
Primary Outcome
Primary outcome measure is the rate of symptomatic esophageal stricture formation.
Interventions
- DRUG placebo
- DRUG prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Why NCT02039115 stopped before completion
NCT02039115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02039115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02039115 about?
NCT02039115 is a clinical study titled "Reduction in Symptomatic Esophageal Stricture Formation". Complete endoscopic resection of early neoplastic Barrett's Esophagus (BE) is a curative procedure. However, a significant proportion of patients develop symptomatic esophageal strictures following Complete Barrett's Eradication (CBE), and this limits the technique, particularly for circumferential ...
What is the current status of trial NCT02039115?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2014-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02039115?
The interventions under investigation include: placebo (DRUG), prednisone (DRUG).
Who is sponsoring clinical trial NCT02039115?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02039115's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia